Use access key #2 to skip to page content.
$13.01 -1.76 (-11.92%)
10/10/2008 4:00 PM

Pharmasset, Inc. (VRUS)

CAPS Rating:
*

A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.

View All Commentary (VRUS)

Recs

4

Avatar majakblue (< 20) Submitted: 1/19/08 12:48 AM : Underperform Start Price: $29.16 VRUS Score: 24.95

Ridiculous run-up. Typical pharma wannabe IPO. It probably will outperform initially as investors raise the price artificially high, and then tank as it becomes clear that the company will not be profitable for years to come if ever. It would be a good investment if you want to time the market. Get out now! Before it goes plop plop fizz fizz. Whoops, thats another drug company. As for me, I am a geneticist -biochemist who has worked for pharma start-ups, and I think it is safer to invest in the lottery.

Report this Post Replies: 0 | Reply

Featured Broker Partners